CD86+ cells could be found infiltrating tumors even in the absence of 177Lu-DOTATATE (Figure 2(C-i) and Figure 2(C-ii)) most likely reflecting some degree of inflammation at the site of graft and expanding tumor. This evidence concerns the gene CD86 and neoplasm.